Nuveen Asset Management, LLC Fate Therapeutics Inc Transaction History

Nuveen Asset Management, LLC

  • $329 Billion
  • Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 299,656 shares of FATE stock, worth $964,892. This represents 0.0% of its overall portfolio holdings.

Number of Shares
299,656
Previous 314,571 4.74%
Holding current value
$964,892
Previous $1.18 Million 86.99%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$3.54 - $8.35 $52,799 - $124,540
-14,915 Reduced 4.74%
299,656 $2.2 Million
Q4 2023

Feb 14, 2024
BUY
$1.65 - $3.94 $45,574 - $108,826
27,621 Added 9.63%
314,571 $1.18 Million
Q3 2023

Nov 14, 2023
SELL
$2.02 - $5.04 $3,577 - $8,925
-1,771 Reduced 0.61%
286,950 $608,000
Q2 2023

Aug 14, 2023
BUY
$4.76 - $6.59 $324,365 - $449,068
68,144 Added 30.89%
288,721 $1.37 Million
Q1 2023

May 15, 2023
SELL
$4.24 - $11.12 $326,081 - $855,194
-76,906 Reduced 25.85%
220,577 $1.26 Million
Q4 2022

Feb 14, 2023
BUY
$9.86 - $23.83 $370,075 - $894,411
37,533 Added 14.44%
297,483 $3 Million
Q3 2022

Nov 14, 2022
SELL
$21.04 - $36.06 $3.63 Million - $6.21 Million
-172,300 Reduced 39.86%
259,950 $5.83 Million
Q2 2022

Aug 15, 2022
SELL
$17.78 - $42.39 $1.12 Million - $2.66 Million
-62,794 Reduced 12.68%
432,250 $10.7 Million
Q1 2022

May 16, 2022
BUY
$29.67 - $60.28 $1.1 Million - $2.23 Million
36,996 Added 8.08%
495,044 $18.7 Million
Q4 2021

Feb 14, 2022
SELL
$47.84 - $64.34 $869,874 - $1.17 Million
-18,183 Reduced 3.82%
458,048 $26.8 Million
Q3 2021

Nov 12, 2021
BUY
$59.27 - $95.73 $436,642 - $705,242
7,367 Added 1.57%
476,231 $28.2 Million
Q2 2021

Aug 16, 2021
BUY
$67.25 - $92.52 $661,672 - $910,304
9,839 Added 2.14%
468,864 $40.7 Million
Q1 2021

May 17, 2021
SELL
$72.16 - $117.4 $413,404 - $672,584
-5,729 Reduced 1.23%
459,025 $37.8 Million
Q4 2020

May 17, 2021
BUY
$38.09 - $100.95 $894,238 - $2.37 Million
23,477 Added 5.32%
464,754 $42.3 Million
Q4 2020

Feb 16, 2021
SELL
$38.09 - $100.95 $2.22 Million - $5.88 Million
-58,246 Reduced 11.66%
441,277 $40.1 Million
Q3 2020

Nov 16, 2020
SELL
$30.41 - $40.5 $956,607 - $1.27 Million
-31,457 Reduced 5.92%
499,523 $20 Million
Q2 2020

Aug 14, 2020
BUY
$20.21 - $35.23 $2.87 Million - $5.01 Million
142,207 Added 36.58%
530,980 $18.2 Million
Q1 2020

May 14, 2020
BUY
$17.28 - $31.88 $801,239 - $1.48 Million
46,368 Added 13.54%
388,773 $8.63 Million
Q4 2019

Feb 14, 2020
BUY
$13.39 - $20.73 $378,307 - $585,684
28,253 Added 8.99%
342,405 $6.7 Million
Q3 2019

Nov 14, 2019
BUY
$15.47 - $22.5 $228,012 - $331,627
14,739 Added 4.92%
314,152 $4.88 Million
Q2 2019

Aug 15, 2019
BUY
$15.61 - $20.44 $3.73 Million - $4.89 Million
239,253 Added 397.69%
299,413 $6.08 Million
Q1 2019

May 14, 2019
SELL
$13.15 - $18.71 $234,582 - $333,767
-17,839 Reduced 22.87%
60,160 $1.06 Million
Q4 2018

Feb 14, 2019
SELL
$11.48 - $16.98 $182,394 - $269,778
-15,888 Reduced 16.92%
77,999 $1 Million
Q3 2018

Nov 13, 2018
BUY
$8.75 - $16.29 $92,916 - $172,983
10,619 Added 12.75%
93,887 $1.53 Million
Q2 2018

Aug 14, 2018
BUY
$9.16 - $13.48 $267,517 - $393,683
29,205 Added 54.02%
83,268 $944,000
Q1 2018

May 14, 2018
BUY
$6.3 - $13.77 $340,596 - $744,447
54,063 New
54,063 $528,000

Others Institutions Holding FATE

# of Institutions
178
Shares Held
124M
Call Options Held
222K
Put Options Held
48.6K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $312M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email